Annual Report 10-11 - Elder Pharmaceuticals Ltd.

Pharmaceuticals Ltd.As At31st March 2011(` in Lacs)As At31st March 2010(` in Lacs)5. Earning per share: 6,422.22 4,950.13 19731720 18857486 19731720 18857486Nominal value of equity share (`) 10/- 10/-Earning per share (`) 32.55 26.25Diluted earning per share (`) 32.55 26.256. Hedging and DerivativesPursuant to ICAI Announcement "Accounting for Derivatives" on the early adoption of Accounting Standard 30 - "Financialpronouncements, company law and other regulatory requirements. Pursuant to the adoption :-a) ` 79.02Reserve Account in the Balance Sheet. ` 501.29 Lacs, onCategory Currency CrossCurrencyAmountIN JPY (Million)CurrencyOption TypePurposeStructured Currency Option JPY USD 665.32 USD Put/JPYCall Hedging7. Segment Information:The company is primarily engaged and deals in pharmaceuticals & related products, which in the context of Accounting located in India and service income accrued in India) and revenues outside India (sales to customers located outside India).Segment Domestic Exports TotalYear ended Year ended Year ended31.03.11 31.03.10 31.03.11 31.03.10 31.03.11 31.03.10Segment Revenue 94,578.38 71,049.46 2349.60 1777.74 96,927.98 72,827.20Segment Assets 27,335.30 19,158.18 912.96 376.58 28,248.26 19,534.76Note : Segment Assets represent amount due from customers8. ` 1334.60 lacs (Previous Year `Consignment Agents.9. ` 848.06 lacs (Previous Year ` 967.25 lacs) and ` 37.40.lacs (Previous Year`` 848.06 lacs and ` 836.94 lacs (Previous Year ` 1097.22 lacs and` 1415.56 lacs) respectively.94